Inhaled drug trial aims to clear sticky mucus from lungs
NCT ID NCT05292950
Summary
This early-stage study tested an inhaled drug called ARO-MUC5AC, designed to reduce thick mucus in the lungs of people with asthma or COPD. It involved 78 healthy volunteers and patients to check if the drug was safe and how it behaved in the body. The main goal was to see if it could be tolerated and to measure its effects on lung function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site 1
Nedlands, 6009, Australia
-
Research Site 1
Auckland, 1010, New Zealand
-
Research Site 1
Bialystok, 15-010, Poland
-
Research Site 1
Seoul, 04763, South Korea
-
Research Site 1
Barcelona, 08017, Spain
-
Research Site 1
Bangkok, 10700, Thailand
-
Research Site 1
Wythenshawe, Manchester, M23 9QZ, United Kingdom
-
Research Site 2
South Brisbane, Queensland, 4101, Australia
-
Research Site 2
Auckland, 1051, New Zealand
-
Research Site 2
Krakow, 31-455, Poland
-
Research Site 2
Jeonju, 54907, South Korea
-
Research Site 3
Oświęcim, 32-600, Poland
-
Research Site 3
Bucheon-si, Gyeonggi-do, 14647, South Korea
Conditions
Explore the condition pages connected to this study.